Monitoring IL-1β Expression in Inflammation Using Transgenic Mice
Author Information
Author(s): Li Limei, Fei Zhaoliang, Ren Jianke, Sun Ruilin, Liu Zhihui, Sheng Zhejin, Wang Long, Sun Xia, Yu Jun, Wang Zhugang, Fei Jian
Primary Institution: Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences
Hypothesis
The transgenic mouse model can be used to study IL-1β gene expression during inflammatory processes.
Conclusion
The transgenic mice model is effective for studying IL-1β gene expression and evaluating anti-inflammatory drug effects.
Supporting Evidence
- Luciferase activity increased significantly in response to LPS treatment in transgenic mice.
- Dexamethasone treatment reduced luciferase expression in inflammatory models.
- IL-1β mRNA levels correlated with luciferase expression in various tissues after LPS treatment.
Takeaway
Scientists created special mice that can show when a substance called IL-1β is active during inflammation, helping to test new medicines.
Methodology
Transgenic mice were created with a luciferase gene driven by the IL-1β promoter, and bioluminescence imaging was used to monitor luciferase expression in response to inflammatory stimuli.
Limitations
The luciferase signal may not directly correlate with IL-1β protein levels due to complex regulatory mechanisms.
Participant Demographics
Transgenic mice were used, with no specific demographic details provided.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website